Verition Fund Management LLC Novo Cure LTD Transaction History

Verition Fund Management LLC

$21.7 Billion
Q3 2025

A detailed history of Verition Fund Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Verition Fund Management LLC holds 95,205 shares of NVCR stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

95,205

Previous 39,307 142.21%

Holding current value

$1.08 Million

Previous $699,000 75.97%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$10.9 - $18.46 $609,288 - $1.03 Million	55,898 Added 142.21%	95,205 $1.23 Million
Q2 2025 Aug 14, 2025	BUY	$15.37 - $19.4 $11,527 - $14,549	750 Added 1.95%	39,307 $699,000
Q1 2025 May 15, 2025	SELL	$17.82 - $30.19 $194,398 - $329,342	-10,909 Reduced 22.05%	38,557 $687,000
Q4 2024 Feb 14, 2025	BUY	$14.54 - $33.41 $719,235 - $1.65 Million	49,466 New	49,466 $1.47 Million
Q2 2024 Aug 14, 2024	BUY	$11.83 - $24.05 $453,384 - $921,716	38,325 Added 81.92%	85,108 $1.46 Million

Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $581,044 - $808,878	46,783 New	46,783 $731,000
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $100,322 - $205,449	2,490 Added 30.47%	10,663 $442,000
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $461,284 - $971,034	8,173 New	8,173 $491,000
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $191,758 - $269,449	-3,188 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $239,355 - $388,904	3,188 New	3,188 $239,000
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $188,892 - $316,338	-1,626 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $212,030 - $366,793	1,626 New	1,626 $361,000
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $524,423 - $1.01 Million	-9,034 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $516,744 - $672,219	9,034 New	9,034 $536,000
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $206,463 - $346,519	-3,619 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $35,584 - $48,869	-521 Reduced 12.58%	3,619 $305,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $256,100 - $404,892	4,140 New	4,140 $310,000
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $271,727 - $406,948	-6,436 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $205,694 - $361,188	6,436 New	6,436 $310,000

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

74.2M

Call Options Held

1.26M

Put Options Held

247K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.19B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Novo Cure LTD Transaction History